Eaton Vance Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$3.28M Buy
129,363
+1,065
+0.8% +$37.4K ﹤0.01% 897
2022
Q2
$4.26M Sell
128,298
-7,372
-5% -$313K 0.01% 858
2022
Q1
$9.79M Buy
135,670
+34,918
+35% +$2.52M 0.01% 697
2021
Q4
$9.25M Buy
100,752
+49,699
+97% +$5.94M 0.01% 637
2021
Q3
$6.44M Buy
51,053
+15,194
+42% +$2.21M 0.01% 662
2021
Q2
$5.96M Sell
35,859
-182
-0.5% -$29.5K 0.01% 731
2021
Q1
$6.55M Buy
36,041
+9,562
+36% +$2.22M 0.01% 663
2020
Q4
$5.29M Buy
+26,479
New +$5.38M 0.01% 686

Other funds holding TDOC

Eaton Vance Management's TDOC Position: Q3 2022 in Review

Eaton Vance Management increased its Teladoc Health (TDOC) stake by 0.83% in Q3 2022, buying an estimated $37.4K and bringing the position to 129,363 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #897.

Eaton Vance Management first reported a position in TDOC in Q4 2020 and has held it in 8 quarters since. The position peaked at $9.79M in Q1 2022. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Eaton Vance Management held 129,363 shares of Teladoc Health worth $3.28M as of Q3 2022.
  • Eaton Vance Management bought 1,065 Teladoc Health shares in Q3 2022, an estimated $37.4K.
  • Teladoc Health made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #897 holding.
  • Eaton Vance Management first reported a position in Teladoc Health in Q4 2020 and has held it in 8 quarters since.
  • Eaton Vance Management's Teladoc Health position peaked at $9.79M in Q1 2022.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.